Welcome. How can we help?
30 Day Trial
30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Subscribe to see current content

2014 Revenue: Alphatec Spine

4Q14 revenue: $53.6MM, +5% (U.S. $35.7MM, flat; ex-U.S. $17.9MM, +14%; U.S. Biologics +14%) 2014 revenue: $207.0MM, +3% (U.S. $137.1MM, +2%; ex-U.S. $69.9MM, +4%)   Estimates g...

2014 Revenue: Wright Medical

4Q14 revenue: $83.3MM, +25% (U.S. $62.4MM, +27%; ex-U.S. $20.8MM, +19%) Foot/Ankle $57.1MM, +34% (Total Ankle +38%) U.S. $46.0MM, +39% Ex-U.S. $11.1MM, +20% Upper Extremity ...

2014 Revenue: Globus Medical

4Q14 revenue: $128.8MMM, +12% (U.S. +13%, ex-U.S. +10%) 2014 revenue: $474.4MM, +9% (U.S. $427.0MM, +8%; ex-U.S. $47.2MM, +25%) Innovative Fusion $270.8MM, +7% Disruptive Technolo...

2014 Revenue: Anika Therapeutics

4Q14 revenue: $13.2MM, -14% 2014 revenue: $61.9MM, +11% (MONOVISC +258%)   4Q revenues impacted by lack of unique CMS J-Code for MONOVISC for 8 months post-launch, DePuy Mitek ...

2014 Revenue: Tornier

4Q14 revenue: $92.4MM, +14% (U.S. $53.7MM, +12%; ex-U.S. $38.6MM, +17%) Total Extremities $76.9MM, +16% Upper $57.5MM, +22% Lower $15.9MM, -1% (Ankle arthroplasty >20%) S...

Page Navigation
First